BONK, INC. 10-K

ITEM 5. MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES The Company’s common stock is traded on the NASDAQ Stock Market LLC under the symbol BNKK, and its warrants are traded under the symbol BNKKW. The following table sets forth the range of high and low bid prices for our common stock for each of the periods indicated as reported by such marketplaces. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions. Period High Low 2025 Fiscal Year: Fourth Quarter Ended December 31, 2025 $ 16.87 $ 2.33 Third Quarter Ended September 30, 2025 $ 46.90 $ 8.64 Second Quarter Ended June 30, 2025 $ 20.01 $ 8.05 First Quarter Ended March 31, 2025 $ 31.15 $ 11.86 2024 Fiscal Year: Fourth Quarter Ended December 31, 2024 $ 47.25 $ 23.45 Third Quarter Ended September 30, 2024 $ 61.95 $ 19.25 Second Quarter Ended June 30, 2024 $ 86.10 $ 35.00 First Quarter Ended March 31, 2024 $ 141.58 $ 59.50 We consider our common stock to be thinly traded and, accordingly, reported sales prices or quotations may not be a true market-based valuation of our common stock. As of March 25, 2026, there were 1,255 holders of record of our common stock, and no holders of record of our warrants. Dividends We do not anticipate paying any cash dividends on our common stock in the foreseeable future and we intend to retain all of our earnings, if any, to finance our growth and operations and to fund the expansion of our business. Payment of any dividends will be made in the discretion of our Board of Directors, after our taking into account various factors, including our financial condition, operating results, current and anticipated cash needs and plans for expansion. No dividends may be declared or paid on our common shares, unless a dividend, payable in the same consideration or manner, is simultaneously declared or paid, as the case may be, on our shares of preferred stock, if any. Issuance of Unregistered Securities There were no sales of unregistered securities during the fiscal year ended December 31, 2025 other than those transactions previously reported to the SEC on our quarterly reports on Form 10-Q and current reports on Form 8-K. Securities Authorized for Issuance under Equity Compensation Plans The information required by Item 5 of this Annual Report regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Form 10-K. 45 Table of Contents ITEM 6. SELECTED FINANCIAL DATA Not applicable to a smaller reporting company.